Skip to content
Home / Companies / BCAX BCA
Bicara Therapeutics Inc. (BCAX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest BCAX Insider Trades
About Bicara Therapeutics Inc. (BCAX) Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
Headquarters BOSTON, MA
Employees 103
Listed 2024
Exchange XNAS https://www.bicara.com SEC filings for BCAX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 12 108,000 $3.08M Grant or award 10 499,225 Option exercise 13 165,000
BCAX Insider Transactions (Form 4) 105 59 Form 4 filings on record, the earliest from Jun 9, 2025, newest first. Filing history page 2 of 2.
Date Insider Transaction Security Shares Price Value Mar 3, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock
Recent BCAX Form 8-K Filings 5
Recent BCAX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 10, 2026 Mazumdar Claire Officer, Director 10,000 $278K View on EDGAR Aug 10, 2026 Hyep Ivan Officer
BCAX Insider Trading - FAQ
What is the latest insider trade for BCAX? Bicara Therapeutics Inc. (BCAX) had 16 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for BCAX runs to 59 Form 4 filings, the earliest from 2025-06-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BCAX stock? No insider purchases of BCAX were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling BCAX stock? 12 insider sales of BCAX were filed in the last 90 days, totaling $3.08M.
Where can I see BCAX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BCAX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BCAX insider buys? Create a free InsiderAlpha account and press Watch on this page to add BCAX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BCAX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $280K
Market cap $1.55B
P/E ratio -
Dividend yield -
Average volume 721.4K
52 week high $30.99
52 week low $10.30
Today's high $24.59
Today's low $23.36
Open $24.45
Volume 524.7K
Previous close $24.83
Shares outstanding 66.17M Market cap
$1.55B
103 employees
BCAX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 12 sales totaling $3.08M.
Most-Active BCAX Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Mar 3, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 12,892 $0.00 -
Mar 3, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 12,892 $3.79 $49K
Mar 3, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 12,892 $18.16 $234K
Mar 4, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 2,963 $3.79 $11K
Mar 4, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 2,963 $18.25 $54K
Mar 3, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 7,318 $0.00 -
Mar 3, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 6,237 $0.00 -
Mar 4, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 2,963 $0.00 -
Mar 3, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 7,318 $3.79 $28K
Mar 3, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 6,237 $3.79 $24K
Mar 3, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 13,555 $18.22 $247K
Mar 4, 2026 DR David Raben - Officer Option exercise Common Stock 16,300 $3.79 $62K
Mar 4, 2026 DR David Raben - Officer Open-market sale Common Stock 16,300 $18.52 $302K
Mar 3, 2026 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 200 $0.00 -
Mar 4, 2026 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 16,300 $0.00 -
Mar 3, 2026 DR David Raben - Officer Option exercise Common Stock 200 $3.79 $758
Mar 3, 2026 DR David Raben - Officer Open-market sale Common Stock 200 $18.45 $4K
Feb 25, 2026 RC Ryan Cohlhepp - Officer Option exercise Common Stock 3,108 $3.79 $12K
Feb 25, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 3,108 $18.04 $56K
Feb 25, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 523 $18.04 $9K
Feb 25, 2026 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 3,108 $0.00 -
Feb 2, 2026 RC Ryan Cohlhepp - Officer Grant or award Stock Option (Right to Buy) 300,000 $0.00 -
Feb 2, 2026 CM Claire Mazumdar - Officer Grant or award Stock Option (Right to Buy) 450,000 $0.00 -
Feb 2, 2026 DR David Raben - Officer Grant or award Stock Option (Right to Buy) 100,000 $0.00 -
Feb 2, 2026 IH Ivan Hyep - Officer Grant or award Stock Option (Right to Buy) 125,000 $0.00 -
Feb 2, 2026 LM Lara Meisner - Officer Grant or award Stock Option (Right to Buy) 90,000 $0.00 -
Jan 22, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 3,828 $18.10 $69K
Jan 22, 2026 IH Ivan Hyep - Officer Option exercise Common Stock 1,882 $3.79 $7K
Jan 22, 2026 IH Ivan Hyep - Officer Open-market sale Common Stock 1,882 $18.15 $34K
Jan 22, 2026 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 1,882 $0.00 -
Jan 15, 2026 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 149 $18.02 $3K
Dec 15, 2025 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
Dec 15, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $18.68 $149K
Dec 15, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,500 $18.68 $84K
Dec 15, 2025 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
Nov 21, 2025 IH Ivan Hyep - Officer Option exercise Common Stock 605 $3.79 $2K
Nov 21, 2025 IH Ivan Hyep - Officer Open-market sale Common Stock 605 $18.15 $11K
Nov 24, 2025 IH Ivan Hyep - Officer Option exercise Common Stock 17,795 $3.79 $67K
Nov 24, 2025 IH Ivan Hyep - Officer Open-market sale Common Stock 17,795 $18.55 $330K
Nov 21, 2025 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 605 $0.00 -
Nov 24, 2025 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 17,795 $0.00 -
Nov 24, 2025 DR David Raben - Officer Option exercise Common Stock 5,500 $3.79 $21K
Nov 24, 2025 DR David Raben - Officer Open-market sale Common Stock 5,500 $18.45 $101K
Nov 25, 2025 DR David Raben - Officer Option exercise Common Stock 4,594 $3.79 $17K
Nov 25, 2025 DR David Raben - Officer Open-market sale Common Stock 4,594 $18.84 $87K
Nov 25, 2025 DR David Raben - Officer Option exercise Common Stock 906 $3.79 $3K
Nov 25, 2025 DR David Raben - Officer Open-market sale Common Stock 906 $18.84 $17K
Nov 24, 2025 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 5,500 $0.00 -
Nov 25, 2025 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 4,594 $0.00 -
Nov 25, 2025 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 906 $0.00 -
Nov 24, 2025 CM Claire Mazumdar - Officer Option exercise Common Stock 41,163 $3.79 $156K
Nov 24, 2025 CM Claire Mazumdar - Officer Open-market sale Common Stock 41,163 $18.86 $776K
Nov 24, 2025 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 41,163 $0.00 -
Nov 21, 2025 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
Nov 21, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $18.05 $144K
Nov 21, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,500 $18.05 $81K
Nov 21, 2025 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
Oct 16, 2025 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 24,103 $0.00 -
Oct 16, 2025 CM Claire Mazumdar - Officer Option exercise Common Stock 24,103 $3.79 $91K
Oct 16, 2025 CM Claire Mazumdar - Officer Open-market sale Common Stock 24,103 $18.83 $454K
Oct 15, 2025 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
Oct 15, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $18.16 $145K
Oct 15, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 4,500 $18.16 $82K
Oct 15, 2025 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
Oct 13, 2025 CM Claire Mazumdar - Officer Option exercise Common Stock 11,445 $3.79 $43K
Oct 13, 2025 CM Claire Mazumdar - Officer Open-market sale Common Stock 11,445 $18.92 $217K
Oct 15, 2025 CM Claire Mazumdar - Officer Option exercise Common Stock 13,289 $3.79 $50K
Oct 15, 2025 CM Claire Mazumdar - Officer Open-market sale Common Stock 13,289 $18.84 $250K
Oct 13, 2025 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 11,445 $0.00 -
Oct 15, 2025 CM Claire Mazumdar - Officer Option exercise Stock Option (Right to Buy) 13,289 $0.00 -
Oct 9, 2025 IH Ivan Hyep - Officer Option exercise Common Stock 6,415 $3.79 $24K
Oct 9, 2025 IH Ivan Hyep - Officer Open-market sale Common Stock 6,415 $18.23 $117K
Oct 9, 2025 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 6,415 $0.00 -
Oct 9, 2025 DR David Raben - Officer Option exercise Common Stock 22,000 $3.79 $83K
Oct 9, 2025 DR David Raben - Officer Open-market sale Common Stock 22,000 $18.45 $406K
Oct 9, 2025 DR David Raben - Officer Option exercise Stock Option (Right to Buy) 22,000 $0.00 -
Oct 6, 2025 IH Ivan Hyep - Officer Option exercise Common Stock 6,514 $3.79 $25K
Oct 6, 2025 IH Ivan Hyep - Officer Open-market sale Common Stock 6,514 $18.17 $118K
Oct 7, 2025 IH Ivan Hyep - Officer Option exercise Common Stock 18,244 $3.79 $69K
Oct 7, 2025 IH Ivan Hyep - Officer Open-market sale Common Stock 18,244 $18.22 $332K
Oct 8, 2025 IH Ivan Hyep - Officer Option exercise Common Stock 5,627 $3.79 $21K
Oct 8, 2025 IH Ivan Hyep - Officer Open-market sale Common Stock 5,627 $18.21 $102K
Oct 6, 2025 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 6,514 $0.00 -
Oct 7, 2025 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 18,244 $0.00 -
Oct 8, 2025 IH Ivan Hyep - Officer Option exercise Stock Option (Right to Buy) 5,627 $0.00 -
Oct 6, 2025 RC Ryan Cohlhepp - Officer Option exercise Common Stock 24,000 $3.79 $91K
Oct 6, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 24,000 $18.06 $433K
Oct 6, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 15,600 $18.06 $282K
Oct 7, 2025 RC Ryan Cohlhepp - Officer Option exercise Common Stock 8,000 $3.79 $30K
Oct 7, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 8,000 $18.06 $144K
Oct 7, 2025 RC Ryan Cohlhepp - Officer Open-market sale Common Stock 2,900 $18.06 $52K
Oct 6, 2025 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 24,000 $0.00 -
Oct 7, 2025 RC Ryan Cohlhepp - Officer Option exercise Stock Option (Right to Buy) 8,000 $0.00 -
Sep 29, 2025 LM Lara Meisner - Officer Option exercise Common Stock 33,807 $9.24 $312K
Sep 29, 2025 LM Lara Meisner - Officer Open-market sale Common Stock 33,807 $14.75 $499K
Sep 29, 2025 LM Lara Meisner - Officer Option exercise Stock Option (Right to Buy) 33,807 $0.00 -
Sep 15, 2025 LM Lara Meisner - Officer Option exercise Common Stock 15,829 $5.45 $86K
Sep 15, 2025 LM Lara Meisner - Officer Open-market sale Common Stock 15,829 $11.49 $182K
Sep 15, 2025 LM Lara Meisner - Officer Option exercise Stock Option (Right to Buy) 6,085 $0.00 -
Sep 15, 2025 LM Lara Meisner - Officer Option exercise Stock Option (Right to Buy) 9,744 $0.00 -
Jun 9, 2025 MP Michael Powell - Director Grant or award Stock Option (Right to Buy) 23,746 $0.00 -
Jun 9, 2025 NL Nils Lonberg - Director Grant or award Stock Option (Right to Buy) 23,746 $0.00 -
Aug 10, 2026 Cohlhepp Ryan Officer, Director 18,750 $522K View on EDGAR
$IONS
IONIS PHARMACEUTICALS INC
Ivan Hyep - OfficerOpen-market sale$350K
Ryan Cohlhepp - Officer
